Control Bionics

Control Bionics is a medical technology company that develops and commercializes advanced assistive communication devices for people with severe movement restrictions. The company's core technology, the NeuroNode, is a wearable electromyography (EMG) sensor that captures bioelectrical signals from the skin's surface to allow users to control computers and mobile devices. This platform is specifically designed for individuals living with conditions such as Amyotrophic Lateral Sclerosis (ALS), Motor Neuron Disease (MND), and spinal cord injuries. By combining EMG with eye-tracking technology, Control Bionics provides a multi-modal solution that adapts to the changing needs of patients as their conditions progress. The company is publicly listed on the Australian Securities Exchange and maintains a significant operational presence in the United States. Their product portfolio has expanded to include autonomous wheelchair control systems and miniature wearable sensors for broader health monitoring applications.